The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
India’s dependency on China for pharma intermediates can change if there is a proper coordination between educational institutes, research institutes and pharma manufacturers
The sensors have been tested for their different level of strains like micro and large scale motion monitoring and have potential applications in biomedical devices, skin electronics, and minimally invasive surgery
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The goal for the project is the identification and optimization of anti-viral compounds.
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
The expanded laboratories and manufacturing facilities at Nansha are expected to come online between Q1 2022 and Q3 2022
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
The price increases are due to the rising costs of raw materials.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
